Rule2026-02926
Rice Bran Wax in Pesticide Formulations; Exemption From the Requirement for a Tolerance
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 13, 2026
Effective
February 13, 2026
Issuing agencies
Environmental Protection Agency
Abstract
This regulation establishes an exemption from the requirement of a tolerance for residues of rice bran wax (CAS Reg. No. 8016-60-2) when used as an inert ingredient (lubricant) on growing crops and raw agricultural commodities pre- and post-harvest, when applied to animals, and in antimicrobial formulations applied to food-contact surfaces in public eating places, dairy-processing equipment, and food- processing equipment and utensils. Micro Powders, Inc., submitted a petition to EPA under the Federal Food, Drug, and Cosmetic Act (FFDCA) requesting establishment of an exemption from the requirement of a tolerance. This regulation eliminates the need to establish a maximum permissible level for residues of rice bran wax when used in accordance with the terms of those exemptions.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 30 (Friday, February 13, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 30 (Friday, February 13, 2026)]
[Rules and Regulations]
[Pages 6789-6793]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-02926]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2023-0514; FRL-13128-01-OCSPP]
Rice Bran Wax in Pesticide Formulations; Exemption From the
Requirement for a Tolerance
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes an exemption from the requirement
of a tolerance for residues of rice bran wax (CAS Reg. No. 8016-60-2)
when used as an inert ingredient (lubricant) on growing crops and raw
agricultural commodities pre- and post-harvest, when applied to
animals, and in antimicrobial formulations applied to food-contact
surfaces in public eating places, dairy-processing equipment, and food-
processing equipment and utensils. Micro Powders, Inc., submitted a
petition to EPA under the Federal Food, Drug, and Cosmetic Act (FFDCA)
requesting establishment of an exemption from the requirement of a
tolerance. This regulation eliminates the need to establish a maximum
permissible level for residues of rice bran wax when used in accordance
with the terms of those exemptions.
DATES: This regulation is effective February 13, 2026. Objections and
requests for hearings must be received on or before April 14, 2026 and
must be filed in accordance with the instructions provided in 40 CFR
part 178 (see also Unit I.C. of this document).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2023-0514, is available online at
<a href="https://www.regulations.gov">https://www.regulations.gov</a>. Additional information about dockets
generally, along with instructions for visiting the docket in-person,
is available at <a href="https://www.epa.gov/dockets">https://www.epa.gov/dockets</a>.
FOR FURTHER INFORMATION CONTACT: Charles Smith, Registration Division
(7505T), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; main telephone
number: (202) 566-1030; email address: <a href="/cdn-cgi/l/email-protection#5f0d1b190d11302b363c3a2c1f3a2f3e71383029"><span class="__cf_email__" data-cfemail="51031517031f3e2538323422113421307f363e27">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
I. Executive Summary
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
<bullet> Crop production (NAICS code 111).
<bullet> Animal production (NAICS code 112).
<bullet> Food manufacturing (NAICS code 311).
<bullet> Pesticide manufacturing (NAICS code 32532).
If you have any questions regarding the applicability of this
proposed action to a particular entity, consult the person listed under
FOR FURTHER INFORMATION CONTACT.
B. What is EPA's authority for taking this action?
EPA is issuing this rulemaking under section 408 of the FFDCA, 21
U.S.C. 346a. FFDCA section 408(c)(2)(A)(i) allows EPA to establish an
exemption from the requirement for a tolerance (the legal limit for a
pesticide chemical residue in or on a food) only if EPA determines that
the exemption is ``safe.'' FFDCA section 408(c)(2)(A)(ii) defines
``safe'' to mean that ``there is a reasonable certainty that no harm
will result from aggregate exposure to the pesticide chemical residue,
including all anticipated dietary exposures and all other exposures for
which there is reliable information.'' This includes exposure through
drinking water and in residential settings but does not include
occupational exposure. Pursuant to FFDCA section 408(c)(2)(B), in
establishing or maintaining in effect an exemption from the requirement
of a tolerance, EPA must take into account the factors set forth in
FFDCA section 408(b)(2)(C), which require EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue . .
. . '' Additionally, FFDCA section 408(b)(2)(D) requires that the
Agency consider, among other things, ``available information concerning
the cumulative effects of a particular pesticide's residues'' and
``other substances that have a common mechanism of toxicity.''
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a(g), any person may file
an objection to any aspect of this regulation and may also request a
hearing on those objections. If you fail to file an objection to the
final rule within the time period specified in the final rule, you will
have waived the right to raise any issues resolved in the final rule.
You must file your objection or request a hearing on this regulation in
accordance with the instructions provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must identify the docket ID number EPA-HQ-
OPP-2023-0514 in the subject line on the first page of your submission.
All objections and requests for a hearing must be in writing and must
be received by the Hearing Clerk on or before April 14, 2026.
[[Page 6790]]
EPA's Office of Administrative Law Judges (OALJ), in which the
Hearing Clerk is housed, urges parties to file and serve documents by
electronic means only, notwithstanding any other particular
requirements set forth in other procedural rules governing those
proceedings. See ``Revised Order Urging Electronic Filing and
Service,'' dated June 22, 2023, which can be found at <a href="https://www.epa.gov/system/files/documents/2023-06/2023-06-22%20%20revised%20order%20urging%20electronic%20filing%20and%20service.pdf">https://www.epa.gov/system/files/documents/2023-06/2023-06-22%20%20revised%20order%20urging%20electronic%20filing%20and%20service.pdf</a>. Although EPA's regulations require submission via U.S. Mail or hand
delivery, EPA intends to treat submissions filed via electronic means
as properly filed submissions; therefore, EPA believes the preference
for submission via electronic means will not be prejudicial. When
submitting documents to the OALJ electronically, a person should
utilize the OALJ e-filing system at <a href="https://yosemite.epa.gov/oa/eab/eab-alj_upload.nsf">https://yosemite.epa.gov/oa/eab/eab-alj_upload.nsf</a>.
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket at <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Follow
the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute. If you wish to
include CBI in your request, please follow the applicable instructions
at <a href="https://www.epa.gov/dockets/commenting-epa-dockets#rules">https://www.epa.gov/dockets/commenting-epa-dockets#rules</a> and clearly
mark the information that you claim to be CBI. Information not marked
confidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA
without prior notice.
II. Petitioned for Exemption
In the Federal Register of November 21, 2023 (88 FR 81021, FRL-
10579-10-OCSPP), EPA issued a document pursuant to FFDCA section 408,
21 U.S.C. 346a, announcing the filing of a pesticide petition (PP IN-
11778) by Micro Powders, Inc. (EPA Company Number 102655, 580 White
Plains Road, Tarrytown, NY 10591 USA). The petition requested that 40
CFR be amended by establishing an exemption from the requirement of a
tolerance for residues of rice bran wax (CAS Reg. No. 8016-60-2) when
used as an inert ingredient (lubricant) in pesticide formulations
applied to growing crops or raw agricultural commodities pre- and post-
harvest under 40 CFR 180.910, when applied to animals under 40 CFR
180.930, and when used in antimicrobial formulations (food-contact
surface sanitizing solutions) applied to food-contact surfaces in
public eating places, dairy-processing equipment, and food-processing
equipment and utensils under 40 CFR 180.940(a). That document
referenced a summary of the petition prepared by Micro Powders, Inc.,
the petitioner, which is available in the docket (EPA-HQ-OPP-2023-0514)
available online at <a href="https://www.regulations.gov">https://www.regulations.gov</a>. There were no comments
received in response to the notice of filing.
III. Inert Ingredient Definition
Inert ingredients are all substances (or groups of similar
substances) that are intentionally included in a pesticide product,
other than active ingredients as defined in 40 CFR 153.125. Inert
ingredients include, but are not limited to, the following types of
ingredients (except when they have a pesticidal efficacy of their own):
solvents such as alcohols and hydrocarbons; surfactants such as
polyoxyethylene polymers and fatty acids; carriers such as clay and
diatomaceous earth; thickeners such as carrageenan and modified
cellulose; wetting, spreading, and dispersing agents; propellants in
aerosol dispensers; microencapsulating agents; and emulsifiers. The
term ``inert'' is not intended to imply nontoxicity; the ingredient may
or may not be chemically active. Generally, EPA has exempted inert
ingredients from the requirement of a tolerance based on the low
toxicity of the individual inert ingredients.
IV. Aggregate Risk Assessment and Determination of Safety
EPA establishes exemptions from the requirement of a tolerance only
in those cases where it can be clearly demonstrated that the risks from
aggregate exposure to pesticide chemical residues under reasonably
foreseeable circumstances will pose no harm to human health. In order
to determine the risks from aggregate exposure to pesticide inert
ingredients, the Agency considers the toxicity of the inert in
conjunction with possible exposure to residues of the inert ingredient
through food, drinking water, and other exposures that occur as a
result of pesticide use in residential settings. If EPA is able to
determine that a finite tolerance is not necessary to ensure that there
is a reasonable certainty that no harm will result from aggregate
exposure to the inert ingredient, an exemption from the requirement of
a tolerance may be established.
Consistent with FFDCA section 408(c)(2)(A), and the factors
specified in FFDCA section 408(c)(2)(B), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for rice bran wax including
exposure resulting from the exemption established by this action. EPA's
assessment of exposures and risks associated with rice bran wax
follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered their
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children. Specific information on the studies received and the nature
of the adverse effects caused by rice bran wax as well as the no-
observed-adverse-effect-level (NOAEL) and the lowest-observed-adverse-
effect-level (LOAEL) from the toxicity studies are discussed in this
unit.
The toxicological database of rice bran wax is supported by data
regarding surrogates (Carnauba wax, D-002, D-003, [gamma]-Oryzanol,
Docosanoic Acid). EPA has determined that it is appropriate to bridge
surrogate (Micro Powders, Inc.) data to assess rice bran wax due to
similarities in the functional groups/structure (long-chain aliphatic
esters, fatty acids, and alcohols), composition (natural plant wax
mixtures), and physical/chemical properties (high molecular weight, low
water solubility, low vapor pressure), and the available human health
toxicity and ecological toxicity data of the five surrogate substances.
Rice bran wax has low acute toxicity via the oral route, and it is
anticipated to have low toxicity via the dermal and inhalation routes.
Rice bran wax is not an acute eye or dermal irritant, nor a skin
sensitizer. Repeated dose toxicity was evaluated comprehensively using
surrogate data. Subchronic toxicity studies with D-002 and D-003 in
rats (90-day gavage) showed no adverse effects at doses up to 1,500
milligrams per kilogram per day (mg/kg/day). Carnauba wax administered
in rat diet at up to 10 percent (approximately 8,800 to 10,200 mg/kg
body weight per day) for 13 weeks produced no treatment-related
effects. A three-generation reproductive toxicity study with carnauba
wax in rats demonstrated no reproductive or developmental toxicity
[[Page 6791]]
at dietary concentrations up to 1 percent (approximately 10,000 mg/kg/
day). Chronic toxicity studies with carnauba wax (28 weeks in dogs) and
D-003 (9 months in dogs, 18 months in mice, 24 months in rats) at doses
up to 1,500 mg/kg/day showed no treatment-related adverse effects.
Mutagenicity was assessed using an Ames bacterial reverse mutation
test with rice bran wax oxidized in Salmonella typhimurium and it
showed no evidence of mutagenic activity in any tested strain.
Carcinogenicity was evaluated using surrogate data. Two-year dietary
carcinogenicity bioassays with [gamma]-oryzanol in Fischer 344 rats and
B6C3F1 mice showed no increase in tumor incidence at doses up to 2,000
mg/kg/day. Carcinogenicity studies with D-003 in Sprague-Dawley rats
(24 months) and OFI mice (18 months) at doses up to 1,500 mg/kg/day
showed no evidence of carcinogenic potential. These data support a
determination that rice bran wax is not likely to be carcinogenic to
humans.
B. Toxicological Points of Departure/Levels of Concern
Once a pesticide's toxicological profile is determined, EPA
identifies toxicological points of departure (POD) and levels of
concern to use in evaluating the risk posed by human exposure to the
pesticide. For hazards that have a threshold below which there is no
appreciable risk, the toxicological POD is used as the basis for
derivation of reference values for risk assessment. PODs are developed
based on a careful analysis of the doses in each toxicological study to
determine the NOAEL dose and the LOAEL dose. Uncertainty/safety factors
are used in conjunction with the POD to calculate a safe exposure
level, generally referred to as a population-adjusted dose (PAD) or a
reference dose (RfD), and a safe margin of exposure (MOE). For non-
threshold risks, the Agency assumes that any amount of exposure will
lead to some degree of risk. Thus, the Agency estimates risk in terms
of the probability of an occurrence of the adverse effect expected in a
lifetime. For more information on the general principles EPA uses in
risk characterization and a complete description of the risk assessment
process, see <a href="https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/overview-risk-assessment-pesticide-program">https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/overview-risk-assessment-pesticide-program</a>.
The hazard profile of rice bran wax is adequately defined. Overall,
rice bran wax is of low acute, subchronic, and developmental toxicity.
No systemic toxicity is observed up to 1,000 mg/kg/day. Since signs of
toxicity were not observed, no toxicological endpoints of concern or
PODs were identified. Therefore, the Agency performed a qualitative
risk assessment.
C. Exposure Assessment
1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to rice bran wax, EPA considered exposure under the proposed
exemption from the requirement of a tolerance. Dietary exposure (food
and drinking water) to rice bran wax may occur following ingestion of
foods with residues from their use in accordance with this exemption.
However, a quantitative dietary exposure assessment is not necessary
since a toxicological endpoint for risk assessment was not identified.
2. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., textiles (clothing and diapers), carpets, swimming
pools, and hard surface disinfection on walls, floors, tables).
Rice bran wax may be present in pesticide and non-pesticide
products that may be used in and around the home. However, a
quantitative residential exposure assessment is not necessary since a
toxicological endpoint for risk assessment was not identified.
3. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
Based on the lack of toxicity in the available database, EPA has
not found rice bran wax to share a common mechanism of toxicity with
any other substances, and rice bran wax does not appear to produce a
toxic metabolite produced by other substances. For the purposes of this
tolerance exemption, therefore, EPA has assumed that rice bran wax does
not have a common mechanism of toxicity with other substances. For
information regarding EPA's efforts to determine which chemicals have a
common mechanism of toxicity and to evaluate the cumulative effects of
such chemicals, see EPA's website at <a href="https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides">https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides</a>.
D. Additional Safety Factor for the Protection of Infants and Children
Section 408(b)(2)(C) of FFDCA provides that EPA shall apply an
additional tenfold (10X) margin of safety for infants and children in
the case of threshold effects to account for prenatal and postnatal
toxicity and the completeness of the database on toxicity and exposure
unless EPA determines based on reliable data that a different margin of
safety will be safe for infants and children. This additional margin of
safety is commonly referred to as the FQPA Safety Factor (SF). In
applying this provision, EPA either retains the default value of 10X,
or uses a different additional safety factor when reliable data
available to EPA support the choice of a different factor.
Based on an assessment of rice bran wax, EPA has concluded that
there are no toxicological endpoints of concern for the U.S.
population, including infants and children. Because there are no
threshold effects associated with rice bran wax, EPA conducted a
qualitative assessment. As part of that assessment, the Agency did not
use safety factors for assessing risk, and no additional safety factor
is needed for assessing risk to infants and children.
E. Aggregate Risks and Determination of Safety
Because no toxicological endpoints of concern were identified, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, or to infants and children from aggregate
exposure to rice bran wax residues.
F. Analytical Enforcement Methodology
An analytical method is not required for enforcement purposes since
the Agency is establishing an exemption from the requirement of a
tolerance without any numerical limitation.
G. Conclusions
Therefore, an exemption from the requirement of a tolerance is
established for residues of rice bran wax (CAS Reg. No. 8016-60-2) when
used as an inert ingredient (lubricant) in pesticide formulations
applied to growing crops and raw agricultural commodities after harvest
under 40 CFR 180.910; when applied to animals under 40 CFR 180.930; and
when used in antimicrobial formulations applied to food-contact
surfaces in public eating places, dairy-processing equipment, and food-
processing equipment and utensils under 40 CFR 180.940(a).
[[Page 6792]]
V. Statutory and Executive Order Reviews
Additional information about these statutes and Executive Orders
can be found at <a href="https://www.epa.gov/regulations/and-executive-orders">https://www.epa.gov/regulations/and-executive-orders</a>.
A. Executive Order 12866: Regulatory Planning and Review
This action is exempt from review under Executive Order 12866 (58
FR 51735, October 4, 1993), because it establishes or modifies a
pesticide tolerance or a tolerance exemption under FFDCA section 408.
B. Executive Order 14192: Unleashing Prosperity Through Deregulation
Executive Order 14192 (90 FR 9065, February 6, 2025) does not apply
because actions that establish a tolerance under FFDCA section 408 are
exempted from review under Executive Order 12866.
C. Paperwork Reduction Act (PRA)
This action does not impose an information collection burden under
the PRA 44 U.S.C. 3501 et seq., because it does not contain any
information collection activities.
D. Regulatory Flexibility Act (RFA)
This action is not subject to the RFA, 5 U.S.C. 601 et seq. The RFA
applies only to rules subject to notice and comment rulemaking
requirements under the Administrative Procedure Act (APA), 5 U.S.C.
553, or any other statute. This rule is not subject to the APA but is
subject to FFDCA section 408(d), which does not require notice and
comment rulemaking to take this action in response to a petition.
E. Unfunded Mandates Reform Act (UMRA)
This action does not contain an unfunded mandate of $100 million or
more (in 1995 dollars and adjusted annually for inflation) as described
in UMRA, 2 U.S.C. 1531-1538, and does not significantly or uniquely
affect small governments. The action imposes no enforceable duty on any
state, local or tribal governments or the private sector.
F. Executive Order 13132: Federalism
This action does not have federalism implications as specified in
Executive Order 13132 (64 FR 43255, August 10, 1999), because it will
not have substantial direct effects on the States, on the relationship
between the National Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
G. Executive Order 13175: Consultation and Coordination With Indian
Tribal Governments
This action does not have tribal implications as specified in
Executive Order 13175 (65 FR 67249, November 9, 2000), because it will
not have substantial direct effects on Tribal governments, on the
relationship between the Federal Government and the Indian Tribes, or
on the distribution of power and responsibilities between the Federal
Government and Indian Tribes.
H. Executive Order 13045: Protection of Children From Environmental
Health Risks and Safety Risks
This action is not subject to Executive Order 13045 (62 FR 19885,
April 23, 1997) because it is not a significant regulatory action under
section 3(f)(1) of Executive Order 12866 (See Unit V.A.), and because
EPA does not believe the environmental health or safety risks addressed
by this action present a disproportionate risk to children.
However, EPA's 2021 Policy on Children's Health applies to this
action. This rule finalizes tolerance actions under the FFDCA, which
requires EPA to give special consideration to exposure of infants and
children to the pesticide chemical residue in establishing a tolerance
and to ``ensure that there is a reasonable certainty that no harm will
result to infants and children from aggregate exposure to the pesticide
chemical residue . . .'' (FFDCA 408(b)(2)(C)). The Agency's
consideration is documented in the pesticide-specific review documents,
located in the applicable docket at <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
I. Executive Order 13211: Actions Concerning Regulations That
Significantly Affect Energy Supply, Distribution or Use
This action is not subject to Executive Order 13211 (66 FR 28355)
(May 22, 2001) because it is not a significant regulatory action under
Executive Order 12866.
J. National Technology Transfer Advancement Act (NTTAA)
This action does not involve technical standards that would require
Agency consideration under NTTAA section 12(d), 15 U.S.C. 272.
K. Congressional Review Act (CRA)
This action is subject to the CRA, 5 U.S.C. 801 et seq., and EPA
will submit a rule report to each House of the Congress and to the
Comptroller General of the United States. This action does not meet the
criteria set forth in 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: February 9, 2026.
Charles Smith,
Director, Registration Division, Office of Pesticide Programs.
For the reasons stated in the preamble, the EPA amends 40 CFR
chapter I as follows:
PART 180--TOLERANCES AND EXEMPTIONS FOR PESTICIDE CHEMICAL RESIDUES
IN FOOD
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. In Sec. 180.910, amend Table 1 to Sec. 180.910 by adding, in
alphabetical order, an entry for ``rice bran wax'' to read as follows:
Sec. 180.910 Inert ingredients used pre- and post-harvest;
exemptions from the requirement of a tolerance.
* * * * *
Table 1 to 180.910
------------------------------------------------------------------------
Inert ingredients Limits Uses
------------------------------------------------------------------------
* * * * * * *
Rice bran wax (CAS Reg. No. None............. Lubricant.
8016-60-2).
* * * * * * *
------------------------------------------------------------------------
[[Page 6793]]
0
3. In Sec. 180.930, amend Table 1 to Sec. 180.930 by adding, in
alphabetical order, an entry for ``rice bran wax'' to read as follows:
Sec. 180.930 Inert ingredients applied to animals; exemptions from
the requirement of a tolerance.
* * * * *
Table 1 to 180.930
------------------------------------------------------------------------
Inert ingredients Limits Uses
------------------------------------------------------------------------
* * * * * * *
Rice bran wax (CAS Reg. No. None............. Lubricant.
8016-60-2).
* * * * * * *
------------------------------------------------------------------------
0
4. In Sec. 180.940, amend Table 1 to paragraph (a) by adding, in
alphabetical order, an entry for ``rice bran wax'' to read as follows:
Sec. 180.940 Tolerance exemptions for active and inert ingredients
for use in antimicrobial formulations (Food-contact surface sanitizing
solutions).
* * * * *
Table 1 to Paragraph (a)
------------------------------------------------------------------------
Inert ingredients CAS Reg. No. Limits
------------------------------------------------------------------------
* * * * * * *
Rice bran wax................. 8016-60-2 None.
* * * * * * *
------------------------------------------------------------------------
* * * * *
[FR Doc. 2026-02926 Filed 2-12-26; 8:45 am]
BILLING CODE 6560-50-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 13, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.